Jubilant Ingrevia Ltd.
Fundamentals
- Market cap
- ₹9,902 cr
- P/E
- 35.63×
- ROE
- 8.58%
- Debt / equity
- 0.26
- Div yield
- 0.40%
- 52-week range
- 537.30 — 851.80
Company snapshot
Jubilant Ingrevia Ltd.
Chemicals
₹10,194 cr
P/E 36.68×
Latest quarter · Mar 2026
Sales₹1,179 cr
Net profit₹86 cr
Op. margin+13.8%
EPS₹5.48
Strength & growth
Debt / equity0.26×
Current ratio1.32×
The timeline — 5 notes on Jubilant Ingrevia Ltd.
May 2026
- 29 May 26 · 8:11 PM IST Brief Brief · Earnings · Mid cap
Jubilant Ingrevia's call transcript quantifies a ₹3,500 cr CDMO pipeline
The verbatim Q4/FY26 call transcript provides the peak-revenue estimate for over 100 CDMO opportunities and details a hedge against customer stress.
- 26 May 26 · 6:11 PM IST Brief Brief · Mid cap
Jubilant Ingrevia's $300M agro client faces financial distress
The client for the company's flagship CDMO contract is in trouble. While make-whole provisions exist, the volume ramp-up is now in doubt.
- 26 May 26 · 3:00 PM IST Brief Brief · Earnings · Mid cap
Jubilant Ingrevia posts highest profit in 14 quarters on volume recovery
Q4 revenue rose 12% as the company navigated Middle East disruptions and commissioned a new agro CDMO plant. Management guides for sequential growth to start FY27.
- 26 May 26 · 3:00 PM IST Brief Brief · Earnings · Mid cap
Jubilant Ingrevia hits 14-quarter revenue high, guides for more
Q4 sales reached ₹1,179 cr, the highest in three and a half years. Volume drove the growth, not price.
- 26 May 26 · 2:43 PM IST Brief Brief · Earnings · Mid cap
Jubilant Ingrevia's FY26 profit grows 10.6%. The numbers were expected.
A routine annual result. Consolidated profit hits ₹278 crore on a 5% revenue increase. A ₹13 crore one-time charge is the only wrinkle.